AMRX
Price
$7.45
Change
+$0.15 (+2.05%)
Updated
Apr 24, 02:16 PM (EDT)
Capitalization
1.87B
8 days until earnings call
VTRS
Price
$8.13
Change
+$0.31 (+3.97%)
Updated
Apr 24, 02:54 PM (EDT)
Capitalization
14.18B
14 days until earnings call
Ad is loading...

AMRX vs VTRS

Header iconAMRX vs VTRS Comparison
Open Charts AMRX vs VTRSBanner chart's image
Amneal Pharmaceuticals
Price$7.45
Change+$0.15 (+2.05%)
Volume$400
Capitalization1.87B
Viatris
Price$8.13
Change+$0.31 (+3.97%)
Volume$42.36K
Capitalization14.18B
AMRX vs VTRS Comparison Chart
Loading...
AMRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VTRS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
AMRX vs. VTRS commentary
Apr 24, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AMRX is a StrongBuy and VTRS is a Buy.

Ad is loading...
COMPARISON
Comparison
Apr 24, 2025
Stock price -- (AMRX: $7.30 vs. VTRS: $7.81)
Brand notoriety: AMRX and VTRS are both not notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: AMRX: 64% vs. VTRS: 63%
Market capitalization -- AMRX: $1.87B vs. VTRS: $14.18B
AMRX [@Pharmaceuticals: Other] is valued at $1.87B. VTRS’s [@Pharmaceuticals: Other] market capitalization is $14.18B. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $77.48B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $3.65B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AMRX’s FA Score shows that 1 FA rating(s) are green whileVTRS’s FA Score has 2 green FA rating(s).

  • AMRX’s FA Score: 1 green, 4 red.
  • VTRS’s FA Score: 2 green, 3 red.
According to our system of comparison, both AMRX and VTRS are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AMRX’s TA Score shows that 6 TA indicator(s) are bullish while VTRS’s TA Score has 5 bullish TA indicator(s).

  • AMRX’s TA Score: 6 bullish, 5 bearish.
  • VTRS’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, VTRS is a better buy in the short-term than AMRX.

Price Growth

AMRX (@Pharmaceuticals: Other) experienced а +1.67% price change this week, while VTRS (@Pharmaceuticals: Other) price change was +5.68% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +2.44%. For the same industry, the average monthly price growth was -4.70%, and the average quarterly price growth was -11.48%.

Reported Earning Dates

AMRX is expected to report earnings on Aug 07, 2025.

VTRS is expected to report earnings on Aug 11, 2025.

Industries' Descriptions

@Pharmaceuticals: Other (+2.44% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
VTRS($14.2B) has a higher market cap than AMRX($1.87B). VTRS has higher P/E ratio than AMRX: VTRS (238.80) vs AMRX (90.00). AMRX YTD gains are higher at: -7.828 vs. VTRS (-36.479). VTRS has higher annual earnings (EBITDA): 3.52B vs. AMRX (400M). VTRS has more cash in the bank: 1.18B vs. AMRX (91.5M). AMRX has less debt than VTRS: AMRX (2.75B) vs VTRS (18.4B). VTRS has higher revenues than AMRX: VTRS (15.4B) vs AMRX (2.39B).
AMRXVTRSAMRX / VTRS
Capitalization1.87B14.2B13%
EBITDA400M3.52B11%
Gain YTD-7.828-36.47921%
P/E Ratio90.00238.8038%
Revenue2.39B15.4B16%
Total Cash91.5M1.18B8%
Total Debt2.75B18.4B15%
FUNDAMENTALS RATINGS
AMRX vs VTRS: Fundamental Ratings
AMRX
VTRS
OUTLOOK RATING
1..100
1210
VALUATION
overvalued / fair valued / undervalued
1..100
94
Overvalued
12
Undervalued
PROFIT vs RISK RATING
1..100
48100
SMR RATING
1..100
9691
PRICE GROWTH RATING
1..100
6065
P/E GROWTH RATING
1..100
211
SEASONALITY SCORE
1..100
7550

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

VTRS's Valuation (12) in the null industry is significantly better than the same rating for AMRX (94) in the Pharmaceuticals Major industry. This means that VTRS’s stock grew significantly faster than AMRX’s over the last 12 months.

AMRX's Profit vs Risk Rating (48) in the Pharmaceuticals Major industry is somewhat better than the same rating for VTRS (100) in the null industry. This means that AMRX’s stock grew somewhat faster than VTRS’s over the last 12 months.

VTRS's SMR Rating (91) in the null industry is in the same range as AMRX (96) in the Pharmaceuticals Major industry. This means that VTRS’s stock grew similarly to AMRX’s over the last 12 months.

AMRX's Price Growth Rating (60) in the Pharmaceuticals Major industry is in the same range as VTRS (65) in the null industry. This means that AMRX’s stock grew similarly to VTRS’s over the last 12 months.

VTRS's P/E Growth Rating (1) in the null industry is in the same range as AMRX (21) in the Pharmaceuticals Major industry. This means that VTRS’s stock grew similarly to AMRX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
AMRXVTRS
RSI
ODDS (%)
Bullish Trend 2 days ago
84%
Bullish Trend 2 days ago
64%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
90%
Bearish Trend 2 days ago
62%
Momentum
ODDS (%)
Bullish Trend 2 days ago
85%
Bullish Trend 2 days ago
64%
MACD
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
67%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
64%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
74%
Bearish Trend 2 days ago
64%
Advances
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
67%
Declines
ODDS (%)
Bearish Trend 17 days ago
77%
Bearish Trend 9 days ago
66%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
61%
Aroon
ODDS (%)
Bearish Trend 2 days ago
71%
Bearish Trend 2 days ago
68%
View a ticker or compare two or three
Ad is loading...
AMRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VTRS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
CRYPTO / NAMEPrice $Chg $Chg %
NKN.X0.0324600.002730
+9.18%
NKN cryptocurrency
VTHO.X0.0026600.000098
+3.82%
VeThor Token cryptocurrency
POND.X0.0095130.000304
+3.30%
Marlin cryptocurrency
LTC.X83.225150-0.183159
-0.22%
Litecoin cryptocurrency
FOR.X0.001130-0.000019
-1.69%
ForTube cryptocurrency

AMRX and

Correlation & Price change

A.I.dvisor indicates that over the last year, AMRX has been loosely correlated with HROW. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if AMRX jumps, then HROW could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AMRX
1D Price
Change %
AMRX100%
+0.69%
HROW - AMRX
38%
Loosely correlated
+3.97%
VTRS - AMRX
36%
Loosely correlated
+1.56%
TEVA - AMRX
33%
Poorly correlated
+2.07%
PRGO - AMRX
33%
Poorly correlated
-0.28%
ORGO - AMRX
32%
Poorly correlated
+2.54%
More

VTRS and

Correlation & Price change

A.I.dvisor indicates that over the last year, VTRS has been loosely correlated with AMRX. These tickers have moved in lockstep 36% of the time. This A.I.-generated data suggests there is some statistical probability that if VTRS jumps, then AMRX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VTRS
1D Price
Change %
VTRS100%
+1.56%
AMRX - VTRS
36%
Loosely correlated
+0.69%
ELAN - VTRS
36%
Loosely correlated
+3.37%
PBH - VTRS
36%
Loosely correlated
-0.57%
ZTS - VTRS
33%
Loosely correlated
+0.61%
ALKS - VTRS
32%
Poorly correlated
+0.15%
More